Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer

Published:2023-05-02 Issue:11 Volume:149 Page:8729-8741
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Fan Xingyu,Huang Junfeng,Hu Bingqi,Zhou Jing,Chen Liwen

Funder

The Natural Science Foundation of Anhui Province

Key Research and Development Program of Anhui Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04790-3.pdf

Reference53 articles.

1. Altan M et al (2017) B7–H3 expression in NSCLC and Its association with B7–H4, PD-L1 and tumor-infiltrating lymphocytes. Clin Cancer Res 23(17):5202–5209

2. Andonegui-Elguera MA et al (2020) An overview of vasculogenic mimicry in breast cancer. Front Oncol 10:220

3. Campinho P, Vilfan A, Vermot J (2020) Blood flow forces in shaping the vascular system: a focus on endothelial cell behavior. Front Physiol 11:552

4. Chen Z et al (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14(8):535–546

5. Cheng R et al (2020) CD276 promotes vasculogenic mimicry formation in hepatocellular carcinoma via the PI3K/AKT/MMPs pathway. Oncol Targets Ther 13:11485–11498

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer;BMC Cancer;2024-09-11

2. Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature;Frontiers in Oncology;2024-06-17

3. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process;Experimental Cell Research;2024-04

4. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3;Vaccines;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3